100 research outputs found

    X-shooter Spectroscopy and HST Imaging of 15 Massive Quiescent Galaxies at z ≳ 2

    Get PDF
    We present a detailed analysis of a large sample of spectroscopically confirmed massive quiescent galaxies (MQGs; log(M*/M ⊙) ~ 11.5) at z ≳ 2. This sample comprises 15 galaxies selected in the COSMOS and UDS fields by their bright K-band magnitudes and followed up with Very Large Telescope (VLT) X-shooter spectroscopy and Hubble Space Telescope (HST)/WFC3 H_(F160W) imaging. These observations allow us to unambiguously confirm their redshifts, ascertain their quiescent nature and stellar ages, and reliably assess their internal kinematics and effective radii. We find that these galaxies are compact, consistent with the high-mass end of the stellar mass–size relation for quiescent galaxies at z = 2. Moreover, the distribution of the measured stellar velocity dispersions of the sample is consistent with the most massive local early-type galaxies from the MASSIVE Survey, showing that evolution in these galaxies is dominated by changes in size. The HST images reveal, as surprisingly high, that 40% of the sample has tidal features suggestive of mergers and companions in close proximity, including three galaxies experiencing ongoing major mergers. The absence of velocity dispersion evolution from z = 2 to 0, coupled with a doubling of the stellar mass, with a factor of 4 size increase and the observed disturbed stellar morphologies, supports dry minor mergers as the primary drivers of the evolution of the MQGs over the last 10 billion yr

    Behavioral Response Study on Seismic Airgun and Vessel Exposures in Narwhals

    Get PDF
    One of the last pristine marine soundscapes, the Arctic, is exposed to increasing anthropogenic activities due to climate-induced decrease in sea ice coverage. In this study, we combined movement and behavioral data from animal-borne tags in a controlled sound exposure study to describe the reactions of narwhals, Monodon monoceros, to airgun pulses and ship noise. Sixteen narwhals were live captured and instrumented with satellite tags and Acousonde acoustic-behavioral recorders, and 11 of them were exposed to airgun pulses and vessel sounds. The sound exposure levels (SELs) of pulses from a small airgun (3.4 L) used in 2017 and a larger one (17.0 L) used in 2018 were measured using drifting recorders. The experiment was divided into trials with airgun and ship-noise exposure, intertrials with only ship-noise, and pre- and postexposure periods. Both trials and intertrials lasted ∼4 h on average per individual. Depending on the location of the whales, the number of separate exposures ranged between one and eight trials or intertrials. Received pulse SELs dropped below 130 dB re 1 μPa2 s by 2.5 km for the small airgun and 4–9 km for the larger airgun, and background noise levels were reached at distances of ∼3 and 8–10.5 km, respectively, for the small and big airguns. Avoidance reactions of the whales could be detected at distances >5 km in 2017 and >11 km in 2018 when in line of sight of the seismic vessel. Meanwhile, a ∼30% increase in horizontal travel speed could be detected up to 2 h before the seismic vessel was in line of sight. Applying line of sight as the criterion for exposure thus excludes some potential pre-response effects, and our estimates of effects must therefore be considered conservative. The whales reacted by changing their swimming speed and direction at distances between 5 and 24 km depending on topographical surroundings where the exposure occurred. The propensity of the whales to move towards the shore increased with increasing exposure (i.e., shorter distance to vessels) and was highest with the large airgun used in 2018, where the whales moved towards the shore at distances of 10–15 km. No long-term effects of the response study could be detected

    Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Get PDF
    Most individuals seroconvert after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but being seronegative is observed in 1 to 9%. We aimed to investigate the risk factors associated with being seronegative following PCR-confirmed SARS-CoV-2 infection. In a prospective cohort study, we screened health care workers (HCW) in the Capital Region of Denmark for SARS-CoV-2 antibodies. We performed three rounds of screening from April to October 2020 using an enzyme-linked immunosorbent assay (ELISA) method targeting SARS-CoV-2 total antibodies. Data on all participants’ PCR for SARS-CoV-2 RNA were captured from national registries. The Kaplan-Meier method and Cox proportional hazards models were applied to investigate the probability of being seronegative and the related risk factors, respectively. Of 36,583 HCW, 866 (2.4%) had a positive PCR before or during the study period. The median (interquartile range [IQR]) age of 866 HCW was 42 (31 to 53) years, and 666 (77%) were female. After a median of 132 (range, 35 to 180) days, 21 (2.4%) of 866 were seronegative. In a multivariable model, independent risk factors for being seronegative were self-reported asymptomatic or mild infection hazard ratio (HR) of 6.6 (95% confidence interval [CI], 2.6 to 17; P < 0.001) and body mass index (BMI) of ≥30, HR 3.1 (95% CI, 1.1 to 8.8; P = 0.039). Only a few (2.4%) HCW were not seropositive. Asymptomatic or mild infection as well as a BMI above 30 were associated with being seronegative. Since the presence of antibodies against SARS-CoV-2 reduces the risk of reinfection, efforts to protect HCW with risk factors for being seronegative may be needed in future COVID-19 surges. IMPORTANCE Most individuals seroconvert after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but negative serology is observed in 1 to 9%. We found that asymptomatic or mild infection as well as a BMI above 30 were associated with being seronegative. Since the presence of antibodies against SARS-CoV-2 reduces the risk of reinfection, efforts to protect HCW with risk factors for being seronegative may be needed in future COVID-19 surges

    Whole-Genome and Chromosome Evolution Associated with Host Adaptation and Speciation of the Wheat Pathogen Mycosphaerella graminicola

    Get PDF
    The fungus Mycosphaerella graminicola has been a pathogen of wheat since host domestication 10,000–12,000 years ago in the Fertile Crescent. The wheat-infecting lineage emerged from closely related Mycosphaerella pathogens infecting wild grasses. We use a comparative genomics approach to assess how the process of host specialization affected the genome structure of M. graminicola since divergence from the closest known progenitor species named M. graminicola S1. The genome of S1 was obtained by Illumina sequencing resulting in a 35 Mb draft genome sequence of 32X. Assembled contigs were aligned to the previously sequenced M. graminicola genome. The alignment covered >90% of the non-repetitive portion of the M. graminicola genome with an average divergence of 7%. The sequenced M. graminicola strain is known to harbor thirteen essential chromosomes plus eight dispensable chromosomes. We found evidence that structural rearrangements significantly affected the dispensable chromosomes while the essential chromosomes were syntenic. At the nucleotide level, the essential and dispensable chromosomes have evolved differently. The average synonymous substitution rate in dispensable chromosomes is considerably lower than in essential chromosomes, whereas the average non-synonymous substitution rate is three times higher. Differences in molecular evolution can be related to different transmission and recombination patterns, as well as to differences in effective population sizes of essential and dispensable chromosomes. In order to identify genes potentially involved in host specialization or speciation, we calculated ratios of synonymous and non-synonymous substitution rates in the >9,500 aligned protein coding genes. The genes are generally under strong purifying selection. We identified 43 candidate genes showing evidence of positive selection, one encoding a potential pathogen effector protein. We conclude that divergence of these pathogens was accompanied by structural rearrangements in the small dispensable chromosomes, while footprints of positive selection were present in only a small number of protein coding genes

    Insulin and GH Signaling in Human Skeletal Muscle In Vivo following Exogenous GH Exposure: Impact of an Oral Glucose Load

    Get PDF
    GH induces acute insulin resistance in skeletal muscle in vivo, which in rodent models has been attributed to crosstalk between GH and insulin signaling pathways. Our objective was to characterize time course changes in signaling pathways for GH and insulin in human skeletal muscle in vivo following GH exposure in the presence and absence of an oral glucose load.Eight young men were studied in a single-blinded randomized crossover design on 3 occasions: 1) after an intravenous GH bolus 2) after an intravenous GH bolus plus an oral glucose load (OGTT), and 3) after intravenous saline plus OGTT. Muscle biopsies were taken at t = 0, 30, 60, and 120. Blood was sampled at frequent intervals for assessment of GH, insulin, glucose, and free fatty acids (FFA).GH increased AUC(glucose) after an OGTT (p<0.05) without significant changes in serum insulin levels. GH induced phosphorylation of STAT5 independently of the OGTT. Conversely, the OGTT induced acute phosphorylation of the insulin signaling proteins Akt (ser(473) and thr(308)), and AS160.The combination of OGTT and GH suppressed Akt activation, whereas the downstream expression of AS160 was amplified by GH. WE CONCLUDED THE FOLLOWING: 1) A physiological GH bolus activates STAT5 signaling pathways in skeletal muscle irrespective of ambient glucose and insulin levels 2) Insulin resistance induced by GH occurs without a distinct suppression of insulin signaling proteins 3) The accentuation of the glucose-stimulated activation of AS 160 by GH does however indicate a potential crosstalk between insulin and GH.ClinicalTrials.gov NCT00477997
    corecore